Accelerate Diagnostics, Inc. (AXDXQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0140
+0.0040 (40.00%)
Jun 6, 2025, 4:00 PM EDT
Accelerate Diagnostics Employees
Accelerate Diagnostics had 107 employees as of December 31, 2024. The number of employees decreased by 27 or -20.15% compared to the previous year.
Employees
107
Change (1Y)
-27
Growth (1Y)
-20.15%
Revenue / Employee
$109,327
Profits / Employee
-$467,710
Market Cap
352.61K
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 374 |
CytoDyn | 9 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Accelerate Diagnostics News
- 4 weeks ago - Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - PRNewsWire
- 2 months ago - Accelerate Diagnostics Submits WAVE System and Gram-Negative Positive Blood Culture Menu to the FDA for 510(k) Clearance - PRNewsWire
- 2 months ago - Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 5 months ago - Accelerate Diagnostics Announces Certain Preliminary Fourth Quarter and Full-Year 2024 Results - PRNewsWire
- 7 months ago - Accelerate Diagnostics, Inc. (AXDX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 months ago - Accelerate Diagnostics Reports Third Quarter 2024 Financial Results - PRNewsWire
- 8 months ago - Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results - PRNewsWire
- 8 months ago - Accelerate Diagnostics Announces FDA Clearance of its Accelerate Arc™ System - PRNewsWire